My maiden attempt at Tweetorial-- 💥on STARRT-AKI trial. @NephJC @kidney_boy @Nephro_Sparks @ssfarouk @STARRTAKI @hswapnil
1/
1/
💥Background:
⚡️AKI is associated with high risk of death in ICU
⚡️Initiation of dialysis early has conceivable advantages
⚡️Appropriate timing for dialysis is uncertain
⚡️Previous studies👇 have shown discrepant results
⚡️AKI is associated with high risk of death in ICU
⚡️Initiation of dialysis early has conceivable advantages
⚡️Appropriate timing for dialysis is uncertain
⚡️Previous studies👇 have shown discrepant results
💥Methods:
⚡️168 hospitals in 15 countries
⚡️Eligibility: 18+ yrs, admitted to ICU & AKI; KDIGO 2 or 3
⚡️Exclusion: Emergency dialysis, Advanced CKD, previous h/o dialysis, unusual cause of AKI
4/
⚡️168 hospitals in 15 countries
⚡️Eligibility: 18+ yrs, admitted to ICU & AKI; KDIGO 2 or 3
⚡️Exclusion: Emergency dialysis, Advanced CKD, previous h/o dialysis, unusual cause of AKI
4/
💥Randomization--> assigned in a 1:1 ratio to following👇
⚡️Either accelerated initiation dialysis (starting ASAP or within 12 hours of eligibility)
⚡️Or initiation of dialysis with standard indications: K > 6, pH < 7.2, volume overload, severe respiratory failure
5/
⚡️Either accelerated initiation dialysis (starting ASAP or within 12 hours of eligibility)
⚡️Or initiation of dialysis with standard indications: K > 6, pH < 7.2, volume overload, severe respiratory failure
5/
💥Outcomes
⚡️Primary: death from any cause--at 90 days
⚡️Secondary: dialysis dependence, composite of death or dialysis dependence, or sustained ⬇️kidney function--at 90 days.
6/
⚡️Primary: death from any cause--at 90 days
⚡️Secondary: dialysis dependence, composite of death or dialysis dependence, or sustained ⬇️kidney function--at 90 days.
6/
💥Adverse events: related to dialysis and vascular access were reported through 14 days among ALL patients.
7/
7/
💥Statistical analysis:
⚡️modified intention-to-treat principle
⚡️primary outcome death@ 90 days using chi-square test
⚡️adjusted logistic regression analysis
⚡️kaplan-Meier time-to-event analysis
8/
⚡️modified intention-to-treat principle
⚡️primary outcome death@ 90 days using chi-square test
⚡️adjusted logistic regression analysis
⚡️kaplan-Meier time-to-event analysis
8/
💥Results: from oct 2015 - sept 2019, a total of 11852 pts met provisional eligibility as follows👇
9/
9/
💥Baseline characteristics were well balanced in both the groups. 👇
10/
10/
💥Primary outcome: death at 90 days --> 43.9% in accelerated grp as compared to 43.7% in std grp
RR 1.0(0.93-1.09)
💥Secondary outcome: no significant diff between 2 grps except dialysis dependence at 90 days⚡️higher in accelerated 10.4% vs 6% in std grp. RR 1.74 (1.2-2.4)
11/
RR 1.0(0.93-1.09)
💥Secondary outcome: no significant diff between 2 grps except dialysis dependence at 90 days⚡️higher in accelerated 10.4% vs 6% in std grp. RR 1.74 (1.2-2.4)
11/
💥Summary 👇
12/
12/
💥Limitations:
⚡️individual clinical bias
⚡️introduction of patient heterogeneity with judgement of individual clinician on patients' eligibility
⚡️adverse events occurred more in accelerated group
13/
⚡️individual clinical bias
⚡️introduction of patient heterogeneity with judgement of individual clinician on patients' eligibility
⚡️adverse events occurred more in accelerated group
13/
💥Strengths:
⚡️large sample size
⚡️wide spectrum of ICUs around the world ensuring broad generalization
⚡️clinical equipoise to guide eligibility
⚡️decision on initiation of dialysis for enrolled pts was genuinely uncertain
14/
⚡️large sample size
⚡️wide spectrum of ICUs around the world ensuring broad generalization
⚡️clinical equipoise to guide eligibility
⚡️decision on initiation of dialysis for enrolled pts was genuinely uncertain
14/
💥Conclusion:
Among critically ill patients with AKI, an accelerated renal-replacement strategy was NOT associated with a lower risk of death at 90 days than a standard strategy.
End/ --> thank you 🙏
Among critically ill patients with AKI, an accelerated renal-replacement strategy was NOT associated with a lower risk of death at 90 days than a standard strategy.
End/ --> thank you 🙏
Loading suggestions...